Youll learn what to verify before issuing a prescription, including sterility, ingredient sourcing, and documentation practices that ensure patient safety
Jastreboff AM, et al
lighter or skipped periods suggest metabolic improvement in PCOS-pattern patients Cycle changes lasting beyond 6 months at stable weight or accompanied by severe pain, flooding, or clotting warrant gynecological evaluation, not just dose adjustment Direct answer (40-60 words) Zepbound (tirzepatide) disrupts menstrual cycles through rapid weight loss releasing stored estrogen from adipose tissue, improved insulin sensitivity changing ovulation patterns in metabolically compromised patients, and direct GLP-1 receptor activation affecting hypothalamic-pituitary-ovarian signaling
Food and Drug Administration (FDA) includes vision changes among the possible side effects of semaglutide
What Needs to Change If you're a healthcare provider prescribing these medications, I urge you: Have the full conversation
InThought: Standing out upon too many failures to count in this difficult-to-treat disease, povorcitinib holds its own in sustained improvements in HiSCR50 and will offer an oral alternative and, hopefully, competitive pricing to the HS market served exclusively by biologics
